Common side effects associated with retatrutide consistent with the broader GLP-1 receptor agonist class, as described in the Summary of Product Characteristics (SmPC) for licensed medicines such as Wegovy (semaglutide 2.4 mg) and Mounjaro (tirzepatide) include: Nausea (particularly during dose escalation) Vomiting Diarrhoea or constipation Decreased appetite Injection site reactions such as mild redness or discomfort Increased heart rate , which has been observed with incretin-based therapies These gastrointestinal effects are typically most pronounced when starting treatment or increasing the dose, and they often improve over time as the body adjusts
The fiber content of fruits and vegetables is particularly helpful for weight loss, heart health, and blood sugar control
Our specialists monitor progress closely to adjust your plan safely
Glutathione can reduce inflammation and oxidative stress, which are common factors in these conditions
The fascinating neural connection between GLP-1 pathways and sleep centers reveals why good sleep habits enhance Wegovys effectiveness. For ideal results, patients should prioritize sleep alongside dietary choices and exercise, creating a thorough approach that maximizes Wegovys benefits while minimizing hunger fluctuations